alphaveICICIPRULI₹473.70

ICICI Prudential Life Insurance Company Ltd.

Annual Quarterly₹ CrorePeersSBILIFE HDFCLIFE LICI HDBFS GICRE NAM-INDIA NIACL CRISIL

View

In ₹ Crore except Per Share 12 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026
Total Income	15,637.5	25,320.2	12,015.6	22,302.0	3,782.6
Expenses
Total Expenses	15,343.8	24,943.9	11,530.7	22,333.3	2,150.4
Profit
+ Current Tax	185.2	46.8	46.8	54.9	-401.4
Revenue Detail — as filed
+ Investment Income	223.0	249.6	319.5	279.2	307.8
+ Income from Investments (net)	-904.9	16,648.6	-226.7	10,745.6	-16,302.4
Expense Detail — as filed
+ Advertisement & Publicity	97.8	47.1	60.8	63.9	82.4
+ Employee Remuneration & Welfare	401.0	489.7	465.9	459.5	470.2
+ Commission	1,336.7	909.4	1,272.7	1,237.5	1,795.5
+ Commission (net)	1,575.2	984.9	1,272.7	1,237.5	1,795.5
+ Provision — Diminution in Investments	12.6	0.0	0.0	0.0	-16.1
+ Provision — Doubtful Debts & Write-offs	3.6	4.5	20.4	21.6	11.7
+ Provision — Doubtful Debts incl. Write-off	10.0	0.0	0.0	0.0	0.3
Profit Build-up — Alternate / Pre-Ind-AS Tags
Profit / (Loss) before Tax	412.9	343.4	342.4	443.3	682.8
+ Current Taxes	27.8	42.8	47.8	57.0	58.9
+ Provision for Tax	185.2	46.8	46.8	54.9	-401.4
+ Provisions for Taxes	27.6	42.4	46.6	56.1	58.9
+ Deferred Taxes	-0.2	-0.4	-1.1	-0.9	-0.0
PAT before Extraordinary Items	385.3	301.0	295.8	387.2	623.9
PAT after Extraordinary Items	385.3	301.0	295.8	387.2	623.9
Profit Carried to Balance Sheet	6,670.3	6,848.4	7,144.2	7,531.4	8,155.3
Per Share — as-filed variants
Basic & Diluted EPS before Extraordinary (not annualised)	2.67	2.08	2.05	2.68	4.31
Basic & Diluted EPS after Extraordinary (not annualised)	2.65	2.07	2.03	2.66	4.28
Appropriations & Transfers
Reserves & Surplus excl. Revaluation Reserve	10,514.8	10,730.5	11,057.1	11,493.1	12,181.8
+ Final Dividend	0.0	0.0	0.0	0.0	0.0
Insurance — Revenue Account (Policyholders')
+ Gross Premium Income	16,831.6	8,954.0	12,297.0	12,226.0	19,647.6
+ Net Premium Income	16,369.2	8,503.2	11,843.1	11,809.3	19,180.1
+ First-year Premium	2,709.2	1,445.4	1,975.2	2,081.1	2,930.5
+ Renewal Premium	9,209.4	4,941.7	6,851.8	6,593.9	9,928.2
+ Single Premium	4,913.0	2,567.0	3,470.1	3,551.0	6,788.8
+ Commission — First-year Premium	572.1	280.2	494.2	464.9	839.2
+ Commission — Renewal Premium	216.3	103.3	156.2	131.1	210.1
+ Commission — Single Premium	548.3	525.9	622.3	641.5	746.2
+ Expenses of Management	2,477.7	1,891.5	2,152.0	2,353.6	3,213.8
+ Operating Expenses — Insurance Business	902.5	906.6	879.3	1,116.1	1,418.3
+ Expenses — Non-insurance	65.5	64.6	65.3	59.5	52.3
+ Benefits Paid (net)	12,327.1	9,762.0	11,276.7	12,401.9	13,754.5
+ Change in Actuarial Liability	162.0	13,072.4	-2,119.4	7,493.9	-14,419.4
+ Bonus Allocated to Policyholders	714.6	0.0	0.0	0.0	676.6
+ Interim Bonus Paid	343.2	162.4	213.1	264.7	346.6
+ GST on Linked Charges	175.7	166.8	154.3	7.3	7.4
Surplus in the Revenue Account	293.7	376.2	484.9	-31.3	1,632.2
Net Surplus / (Deficit)	293.7	376.2	484.9	-31.3	1,632.2
+ Funds for Future Appropriation	-82.4	105.6	64.6	65.6	421.0
+ Policyholders' Liabilities to Shareholders' Fund	24.7	24.6	24.0	23.3	21.8
Insurance — Shareholders' Account
+ Income under Shareholders' Account	232.8	258.4	328.7	289.1	438.5
+ Shareholders' Account Income	608.9	529.0	749.0	192.2	1,649.6
+ Shareholders' Account Expenses	196.0	185.7	406.6	-251.0	966.9
+ Shareholders' Provision — Diminution in Investments	0.0	5.1	0.0	0.0	71.3
+ Transfer from Policyholders' Account	376.1	270.6	420.3	-96.9	1,211.2
+ Transfer of Funds to Policyholders' Account	120.6	116.0	341.3	-310.5	843.0
+ Transferred to Shareholders' Account	376.1	270.6	420.3	-96.9	1,211.2
Shareholders' Fund — with Unrealised Gains	0.1	0.2	0.0	0.1	-0.1
Shareholders' Fund — without Unrealised Gains	0.1	0.1	0.1	0.1	0.1
Insurance — Fund NPAs
+ Linked Non-participating — with Unrealised Gains	-0.0	0.0	-0.0	0.0	-0.0
+ Linked Non-participating — without Unrealised Gains	0.0	0.0	0.0	0.0	0.0
+ Non-linked Participating — with Unrealised Gains	0.0	0.0	-0.0	0.0	-0.0
+ Non-linked Participating — without Unrealised Gains	0.0	0.0	0.0	0.0	0.0
+ Non-linked Non-participating — with Unrealised Gains	0.0	0.0	-0.0	0.0	-0.0
+ Non-linked Non-participating — without Unrealised Gains	0.0	0.0	0.0	0.0	0.0
Insurance — IRDAI Ratios (as filed, not percentages)
Solvency Ratio	2.12	2.12	2.13	2.15	2.27
Conservation Ratio	0.81	0.80	0.82	0.82	0.31
Expenses of Management Ratio	0.15	0.21	0.18	0.19	0.16
Persistency — 13th Month	0.84	0.81	0.82	0.81	0.82
Persistency — 25th Month	0.81	0.83	0.79	0.78	0.74
Persistency — 37th Month	0.73	0.73	0.74	0.75	0.75
Persistency — 49th Month	0.69	0.70	0.71	0.70	0.70
Persistency — 61st Month	0.62	0.63	0.59	0.59	0.61
Regulatory Disclosures — filed alongside, not part of the P&L
Investor Complaints — Received	0.00	2.00	0.00	0.00	2.00
Investor Complaints — Disposed	0.00	2.00	0.00	0.00	2.00
Other Filed Concepts — mapped but not yet placed in the schedule
Other Operating Expenses	403.7	369.7	352.6	592.7	865.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q4 FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.